Merck & Co., Inc.'s Profit Falls 90% After Year-Earlier Gain

Bloomberg -- Merck & Co., the second-largest U.S. drugmaker, reported third-quarter profit that rose more than analysts estimated as reduced costs helped overcome revenue losses from drugs facing generic competition.